Improving the translational value of head and neck cancer patient-in-mouse models

NIH RePORTER · NIH · R37 · $65,621 · view on reporter.nih.gov ↗

Abstract

Project Summary Patient-derived model systems are commonly used to study tumor biology and test novel treatments for head and neck cancer. Our goal is to improve the use of mammalian model systems of head and neck cancer to improve treatment outcomes for patients using valid, predictive, well characterized models. The goal of this supplement is to study cancer evolution and therapeutic response with rigorous assessment of tumor biology and genomic alterations to understand how choices made at the time of establishing models impact their relevance over time. Aim 1 will assess the role of heterotopic vs. orthotopic implantation on the therapeutic response and biology of the tumor. Aim 2 will test the concordance of response between patient-derived models and patients. We will use this supplement to support a minority graduate student in the medical physics program to study the effect of radiation on tumor evolution, to provide her with additional training in team science, mentoring, teaching, and communication to support her pursuit of an independent research career.

Key facts

NIH application ID
10598311
Project number
3R37CA255330-02S1
Recipient
UNIVERSITY OF WISCONSIN-MADISON
Principal Investigator
Randall J. Kimple
Activity code
R37
Funding institute
NIH
Fiscal year
2022
Award amount
$65,621
Award type
3
Project period
2021-07-01 → 2026-06-30